This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Sep 20;384(9948):1095.

doi: 10.1016/S0140-6736(14)61671-8.

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes

John S Yudkin¹, Sandeep Vijan², Jeremy B Sussman², Richard Lehman³, Ben M Goldacre⁴

Affiliations

Affiliations

¹ Division of Medicine, University College, London WC1E 6BT, UK. Electronic address: j.yudkin@ucl.ac.uk.
² Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
³ Department of Primary Health Care, University of Oxford, Oxford, UK.
⁴ London School of Hygiene & Tropical Medicine, London, UK.

PMID: 25241716
DOI: 10.1016/S0140-6736(14)61671-8

Comment

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes

John S Yudkin et al. Lancet. 2014.

. 2014 Sep 20;384(9948):1095.

doi: 10.1016/S0140-6736(14)61671-8.

Authors

John S Yudkin¹, Sandeep Vijan², Jeremy B Sussman², Richard Lehman³, Ben M Goldacre⁴

Affiliations

¹ Division of Medicine, University College, London WC1E 6BT, UK. Electronic address: j.yudkin@ucl.ac.uk.
² Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
³ Department of Primary Health Care, University of Oxford, Oxford, UK.
⁴ London School of Hygiene & Tropical Medicine, London, UK.

PMID: 25241716
DOI: 10.1016/S0140-6736(14)61671-8

No abstract available

PubMed Disclaimer

Comment in

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.
Holman RR, Sourij H, Califf RM. Holman RR, et al. Lancet. 2014 Sep 20;384(9948):1097-8. doi: 10.1016/S0140-6736(14)61674-3. Lancet. 2014. PMID: 25241719 No abstract available.

Comment on

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.
Holman RR, Sourij H, Califf RM. Holman RR, et al. Lancet. 2014 Jun 7;383(9933):2008-17. doi: 10.1016/S0140-6736(14)60794-7. Lancet. 2014. PMID: 24910232 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information